Summary
The current nosology of neuropsychiatric disorders provides a pragmatic approach to diagnosis and treatment choice but lacks reference to quantitative biological underpinnings of disease. This weakness impedes innovative drug development. To test whether a quantitative...
More information & hyperlinks
| Web resources: | https://prism2-project.eu/ |
Search
Associated projects
Organisations
- Not specified